Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Leukemia, Myelomonocytic, Chronic 2Anemia, Refractory 2Thrombocytopenia 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Hemoglobinuria, Paroxysmal 1Congenital Abnormalities 1Blast Crisis 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 6Whole-Body Irradiation 5Peripheral Blood Stem Cell Transplantation 5Melphalan 5Tacrolimus 3Mycophenolic Acid 3Methotrexate 3Busulfan 3thymoglobulin 2Cyclosporine 2Cyclophosphamide 2Antilymphocyte Serum 2Alemtuzumab 2treosulfan 1sargramostim 1ravulizumab 1merphos 1bryostatin 1 1X-Rays 1Transplantation, Homologous 1Sirolimus 1Observation 1Granulocyte-Macrophage Colony-Stimulating Factor 1Etoposide 1Cyclosporins 1Bryostatins 1Bone Marrow Transplantation 1Basiliximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemoglobinuria, Paroxysmal × bryostatin 1 × Classical hematology × Clear all
NCT00012376 2013-01-09

Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer

National Cancer Institute (NCI)

Phase 1 Completed
35 enrolled
Classical hematologyOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, Blast Crisis, Hemoglobinuria, Paroxysmal, Thrombocytopenia, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡